Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 127Colonic Neoplasms 54Rectal Neoplasms 49Carcinoma, Hepatocellular 29Stomach Neoplasms 22Neoplasm Metastasis 22Neoplasms 11Pancreatic Neoplasms 9Cholangiocarcinoma 8Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 4Gastrointestinal Neoplasms 4Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Adenocarcinoma 3Unresectable Metastatic Colorectal Cancer 2Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 115Radiotherapy 83Paclitaxel 77Fluorouracil 61Carboplatin 41Drug Therapy 34pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26toripalimab 23Oxaliplatin 23Neoadjuvant Therapy 23Radiation 20sintilimab 19camrelizumab 19130-nm albumin-bound paclitaxel 18Esophagectomy 17Capecitabine 17Surgical Procedures, Operative 15Leucovorin 15Nivolumab 14Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10anlotinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Esophageal Squamous Cell Carcinoma × Folfox protocol × Clear all
NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
245 enrolled 15 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01248299 2019-05-16

E-DIS

Centre Oscar Lambret

Phase 2 Terminated
105 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01605305 2012-05-24

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Fudan University

Phase 2 Completed
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡